Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Nanomaterials (Basel) ; 14(7)2024 Apr 02.
Article in English | MEDLINE | ID: mdl-38607156

ABSTRACT

Inverted organic light-emitting devices (OLEDs) have been aggressively developed because of their superiorities such as their high stability, low driving voltage, and low drop of brightness in display applications. The injection of electrons is a critical issue in inverted OLEDs because the ITO cathode has an overly high work function in injecting electrons into the emission layer from the cathode. We synthesized hexagonal wurtzite ZnO nanoparticles using different oxidizing agents for an efficient injection of electrons in the inverted OLEDs. Potassium hydroxide (KOH) and tetramethylammonium hydroxide pentahydrate (TMAH) were used as oxidizing agents for synthesizing ZnO nanoparticles. The band gap, surface defects, surface morphology, surface roughness, and electrical resistivity of the nanoparticles were investigated. The inverted devices with phosphorescent molecules were prepared using the synthesized nanoparticles. The inverted devices with ZnO nanoparticles using TMAH exhibited a lower driving voltage, lower leakage current, and higher maximum external quantum efficiency. The devices with TMAH-based ZnO nanoparticles exhibited the maximum external quantum efficiency of 19.1%.

2.
Animals (Basel) ; 12(18)2022 Sep 12.
Article in English | MEDLINE | ID: mdl-36139238

ABSTRACT

In this study, we examined the effect of diets supplemented with organic and inorganic mineral premixes on the laying performance and eggshell quality of aged laying hens. A total of 600 68-week-old Hy-Line Brown laying hens were randomly assigned to 1 of 3 dietary treatments, repeated 5 times: Mash type basal diet, basal diet supplemented with an inorganic mineral premix (1.0 g/kg), and basal diet supplemented with an organic mineral premix (1.8 g/kg). The results showed that eggshell strength was higher (p < 0.01) in the inorganic mineral diet group than in the organic mineral and basal diet groups. Further, the levels of Fe and Mn in the liver were higher (p < 0.05) in the inorganic and organic mineral diet groups than in the basal diet group. The concentrations of Fe and Mg in the spleen were different (p < 0.05) among the treatment groups, with the highest levels reported in the organic mineral premix group. The concentrations of Cu, Zn, and Mn in the eggshell were different (p < 0.05) among the groups, with the highest levels reported in the inorganic and organic mineral premix diet groups. In conclusion, a diet containing organic mineral premix improved eggshell strength and had no detrimental effect on the laying performance of aged laying hens.

3.
J Anim Sci Technol ; 64(3): 574-587, 2022 May.
Article in English | MEDLINE | ID: mdl-35709104

ABSTRACT

This study was performed to development the alternative farrowing pen (AFP) and to investigate performance and behavior of lactating sows and their litter. A total of 64 multiparous sows were randomly divided into two groups and were allocated to farrowing crates (FCs) and AFPs. The AFPs contained a crate and support bars that could be folded to provide the sows with extra space on day 5 postpartum. Behavior was recorded by charge-coupled device cameras and digital video recorders, and the data were scanned every 2 min to obtain an instantaneous behavioral sample. Farrowing systems did not affect feed intake, back-fat thickness, litter size and piglet weight at birth and weaning (p > 0.05). In addition, there were no differences in the number of crushed piglets between the two farrowing systems (p > 0.05). However, the weaning-to-estrus interval was shorter in the sows of the AFPs than in thous of the FCs (p < 0.05). The sows spent most of their time lying down during the lactating period, at about 80% lateral recumbency and 10%-15% ventral recumbency. The only significant differences were in the feeding and drinking behavior between sows in the two farrowing systems (p < 0.05). The FC sows displayed more feeding and drinking behavior than the AFP sows, especially in the late lactating period (p < 0.05). Piglets in the FCs tended to spend more time walking than piglets in the AFPs (p < 0.05), whereas there were no differences in suckling and lying behavior between piglets in the two farrowing systems (p > 0.05). It is concluded that the AFPs with temporary crating until day 4 postpartum did not negatively affect performance and crushed piglet compared with the FCs. It also may improve animal welfare by allowing sows to move and turn around during the lactating period. Further research is needed to find suitable housing designs to enhance productivity and animal welfare.

4.
Int Immunopharmacol ; 24(1): 36-41, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25445967

ABSTRACT

When various pathogens invade a host, toll-like receptors (TLRs) play a significant role in recognizing the pathogen-associated molecular patterns carried by the pathogens to induce innate immune reaction, followed by acquired immunity reaction. TLRs have two downstream signaling pathways, the myeloid differential factor 88 (MyD88)-dependent and toll-interleukin-1 receptor domain-containing adapter inducing interferon-ß (TRIF)-dependent pathways. To evaluate the therapeutic potential of 1-[4-fluoro-2-(2-nitrovinyl)phenyl]pyrrolidine (FPP), previously synthesized in our laboratory, its effect on signal transduction via the TLR signaling pathways was examined. FPP inhibited the activation of nuclear factor-κB (NF-κB) and interferon regulatory factor 3 (IRF3) induced by TLR agonists, as well as inhibited the expression of cyclooxygenase-2, inducible nitric oxide synthase, and interferon inducible protein-10. FPP also inhibited the activation of NF-κB and IRF3 when induced by the overexpression of downstream signaling components of the TLRs. As a result, FPP has potential to become a new therapeutic drug for many inflammatory diseases.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Inflammation/drug therapy , Pyrrolidines/therapeutic use , Vinyl Compounds/therapeutic use , Animals , Anti-Inflammatory Agents, Non-Steroidal/chemistry , Cell Line , Chemokine CXCL10/genetics , Chemokine CXCL10/metabolism , Cyclooxygenase 2/genetics , Cyclooxygenase 2/metabolism , Down-Regulation/drug effects , Humans , Interferon Regulatory Factor-3/metabolism , Mice , NF-kappa B/metabolism , Nitric Oxide Synthase Type II/genetics , Nitric Oxide Synthase Type II/metabolism , Pyrrolidines/chemistry , Signal Transduction/drug effects , Toll-Like Receptors/agonists , Vinyl Compounds/chemistry
5.
Eur J Pharmacol ; 742: 42-6, 2014 Nov 05.
Article in English | MEDLINE | ID: mdl-25196213

ABSTRACT

The pathophysiological processes of inflammation can lead to a host of diseases, such as periodontitis, atherosclerosis, rheumatoid arthritis, and even cancer. The dysregulated inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) activation play important roles in the development of certain inflammatory diseases. Here, we investigated the effects of CDr10b which is originally developed for a microglia staining probe on inflammation, by modulating NF-κB activation and iNOS and COX-2 expression induced by lipopolysaccharide (LPS) in murine macrophages. The CDr10b suppressed NF-κB activation and iNOS and COX-2 expression induced by LPS. All the results suggest that CDr10b is a promising novel agent for the treatment of inflammatory diseases.


Subject(s)
Boron Compounds/pharmacology , Cyclooxygenase 2/metabolism , Lipopolysaccharides/pharmacology , Nitric Oxide Synthase Type II/metabolism , Animals , Anti-Inflammatory Agents/pharmacology , Cell Line , Cyclooxygenase 2/genetics , Enzyme Activation/drug effects , Gene Expression/drug effects , Immunologic Factors/pharmacology , Inflammation/drug therapy , Inflammation/metabolism , Macrophages/drug effects , Macrophages/metabolism , Mice , Myeloid Differentiation Factor 88/metabolism , NF-kappa B/metabolism , Nitric Oxide Synthase Type II/genetics , Signal Transduction/drug effects , Toll-Like Receptor 4/metabolism
6.
Fish Shellfish Immunol ; 33(4): 1050-4, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22986588

ABSTRACT

This study was investigated to examine the effects of dietary inosine monophosphate (IMP) supplementation on growth performance, feed utilization, innate immunity, hematological parameters and disease resistance of juvenile olive flounder. Five experimental diets were formulated to contain IMP at levels of 0, 0.1, 0.2, 0.4 and 1.0%. All diets were maintained isonitrogenous (48% crude protein) and isocaloric (20.7 MJ/kg diet). Triplicate groups of olive flounder (initial body weight, 7.5 ± 0.02 g) were fed one of the experimental diets to apparent satiation (twice a day) for 14 weeks. Final body weight of fish fed 0.1-0.2% IMP were significantly higher than that of fish fed the 1.0% IMP. Groups of fish fed 0.2 or 0.4% IMP diet had significantly higher myeloperoxidase and lysozyme activities than fish fed the control diet. However, nitro-blue-tetrazolium and superoxide dismutase activities were not significantly different among all treatments. In the challenge test against Streptococcus iniae, cumulative mortality of fish fed IMP supplemented diets was significantly lower (15%, 4%, 4% and 9% for 0.1%, 0.2%, 0.4% and 1.0% IMP, respectively) than that of fish fed the control group (87%). The results suggest that IMP supplementation of 0.46-1.84 g into a kg of fish meal based diet (0.1-0.4% IMP product) can enhance innate immunity and disease resistance of olive flounder.


Subject(s)
Animal Feed/analysis , Aquaculture , Dietary Supplements , Fish Diseases/immunology , Flounder/immunology , Inosine Monophosphate/administration & dosage , Animal Nutritional Physiological Phenomena , Animals , Blood Chemical Analysis/veterinary , Diet/veterinary , Disease Resistance , Dose-Response Relationship, Drug , Fish Diseases/prevention & control , Flounder/growth & development , Hematocrit/veterinary , Immunity, Innate , Muramidase/metabolism , Random Allocation , Respiratory Burst , Streptococcal Infections/immunology , Streptococcal Infections/prevention & control , Streptococcal Infections/veterinary , Streptococcus/physiology , Superoxide Dismutase/metabolism
7.
Arch Pharm Res ; 29(12): 1140-6, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17225464

ABSTRACT

Ceramide analogs are potential chemotherapeutic agents. We report that a ceramide analog induces apoptosis in human prostate cancer cells. The ceramide analog induced cell death through an apoptotic mechanism, which was demonstrated by DNA fragmentation, the cleavage of poly ADP ribose polymerase (PARP), and a loss of membrane asymmetry. Treating the cells with ceramide analog resulted in the release of various proapoptotic mitochondrial proteins including cytochrome c and Smac/DIBLO into the cytosol, and a decrease in the mitochondrial membrane potential. In addition, the ceramide analog decreased the phospho-Akt and phospho-Bad levels. The expression of the antiapoptotic Bcl-2 decreased slightly with increasing Bax to Bcl-2 ratio. These results suggest that the ceramide analog induces apoptosis by regulating multiple signaling pathways that involve the mitochondrial pathway.


Subject(s)
Apoptosis/drug effects , Ceramides/pharmacology , Prostatic Neoplasms/drug therapy , Blotting, Western , Cell Proliferation/drug effects , Cytochromes c/metabolism , DNA Fragmentation/drug effects , Genes, bcl-2 , Humans , Male , Membrane Potentials/drug effects , Mitochondria/physiology , Neoplasm Proteins/metabolism , Poly(ADP-ribose) Polymerases/metabolism , Prostatic Neoplasms/pathology , Signal Transduction/drug effects , Signal Transduction/physiology , Subcellular Fractions/drug effects , Subcellular Fractions/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...